Latest updates for Vasceptor

Fresh curated links around Vasceptor are collected here so marketers can spot useful updates and turn timely ideas into posts faster.

Recent items include:

  • Vascarta announces NIH Phase I clinical study for sickle cell disease therapy
  • ‘We are proud to be in the lead’: Vaderis lands $152M for phase 3 study in rare blood vessel disorder

Post angles to try

Share the most useful takeaway for your audience.
Turn one article into a quick practical checklist.
Ask your audience how this shift affects their work.
Turn angles into scheduled posts

Fresh articles and ideas

Recent curated links from global sources. Generate one free draft from any story, then use SocialBu to schedule and refine your content calendar.

roi-nj.com /2 weeks ago

Vascarta announces NIH Phase I clinical study for sickle cell disease therapy

Summit-based clinical-stage pharmaceutical company Vascarta announced Aug. 19 that a second proof-of-concept Phase I clinical study of VAS-101 (Vasceptor; topical curcumin gel) in...

Read source
fiercebiotech.com /4 weeks ago

‘We are proud to be in the lead’: Vaderis lands $152M for phase 3 study in rare blood vessel disorder

Vaderis Therapeutics has secured an oversubscribed $152 million series B financing to propel the Swiss biotech's AKT inhibitor through phase 3 with the aim of bringing the first tr...

Read source

Turn fresh research into a full content calendar

Use SocialBu to discover ideas, generate post drafts, and schedule them across your social channels.

Sources covering Vasceptor

fiercebiotech.com

Recent coverage from public sources
Public source

roi-nj.com

Recent coverage from public sources
Public source